Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice

Abstract Background Pyroglutamate-3 Aβ (pGlu-3 Aβ) is an N-terminally truncated and post-translationally modified Aβ species found in Alzheimer’s disease (AD) brain. Its increased peptide aggregation propensity and toxicity make it an attractive emerging treatment strategy for AD. We address the que...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Helen Crehan, Bin Liu, Martin Kleinschmidt, Jens-Ulrich Rahfeld, Kevin X. Le, Barbara J. Caldarone, Jeffrey L. Frost, Thore Hettmann, Birgit Hutter-Paier, Brian O’Nuallain, Mi-Ae Park, Marcelo F. DiCarli, Inge Lues, Stephan Schilling, Cynthia A. Lemere
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-01-01
Colecção:	Alzheimer’s Research & Therapy
Assuntos:	Pyroglutamate-3 amyloid-β Immunotherapy APPSWE/PS1ΔE9 Phagocytosis Microhemorrhage microPET
Acesso em linha:	https://doi.org/10.1186/s13195-019-0579-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!